Scarica l'app Stockscreener
0.8281
0.22%
-0.0018
Dopo l'orario di chiusura:
.82
-0.0081
-0.98%
Precedente Chiudi:
$0.8299
Aprire:
$0.84
Volume 24 ore:
395.35K
Relative Volume:
0.44
Capitalizzazione di mercato:
$11.34M
Reddito:
$1.89M
Utile/perdita netta:
$-17.92M
Rapporto P/E:
-0.1238
EPS:
-6.69
Flusso di cassa netto:
$-15.62M
1 W Prestazione:
+3.54%
1M Prestazione:
-46.92%
6M Prestazione:
-45.88%
1 anno Prestazione:
-60.38%
Intervallo 1D:
$0.82
$0.866
Intervallo di 1 settimana:
$0.765
$0.866
Portata 52W:
$0.633
$2.4843
Longeveron Inc Stock (LGVN) Company Profile
Nome
Longeveron Inc
Settore
Industria
Telefono
305-302-7158
Indirizzo
1951 NW 7TH AVENUE, MIAMI
Confronta LGVN con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
LGVN
Longeveron Inc
|
0.8281 | 17.26M | 1.89M | -17.92M | -15.62M | -6.69 |
|
VRTX
Vertex Pharmaceuticals Inc
|
391.02 | 100.52B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
580.70 | 61.43B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
446.51 | 59.29B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
712.20 | 43.09B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
306.05 | 35.42B | 3.81B | -644.79M | -669.77M | -6.24 |
Longeveron Inc Stock (LGVN) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-12-06 | Iniziato | ROTH MKM | Buy |
Longeveron Inc Borsa (LGVN) Ultime notizie
Ranking Longeveron Inc. among high performing stocks via toolsWeekly Market Report & Growth Focused Stock Reports - Newser
How to use a screener to detect Longeveron Inc. breakoutsQuarterly Market Summary & Weekly Chart Analysis and Guides - Newser
Key resistance and support levels for Longeveron Inc.2025 EndofYear Setup & Consistent Income Trade Recommendations - Newser
How to use Fibonacci retracement on Longeveron Inc.Weekly Stock Report & Fast Gaining Stock Reports - Newser
What machine learning models say about Longeveron Inc.Options Play & High Accuracy Swing Trade Signals - Newser
What’s next for Longeveron Inc. stock priceMarket Weekly Review & Accurate Technical Buy Alerts - Newser
Longeveron Inc. stock volume spike explainedMarket Movers & High Accuracy Buy Signal Tips - Newser
Short interest data insights for Longeveron Inc.July 2025 Selloffs & Accurate Technical Buy Alerts - Newser
Chart based analysis of Longeveron Inc. trendsJuly 2025 Catalysts & Real-Time Market Trend Scan - Newser
How to monitor Longeveron Inc. with trend dashboardsForecast Cut & Real-Time Volume Spike Alerts - Newser
How sensitive is Longeveron Inc. to inflationTrade Performance Summary & Free Real-Time Volume Trigger Notifications - sundaytimes.kr
Relative strength of Longeveron Inc. in sector analysisGlobal Markets & Low Risk High Reward Trade Ideas - Newser
What does recent volatility data suggest for Longeveron Inc.Weekly Gains Report & Fast Exit Strategy with Risk Control - Newser
Will Longeveron Inc. continue its uptrend2025 Analyst Calls & AI Driven Price Predictions - Newser
Understanding Longeveron Inc.’s price movement2025 Volatility Report & Reliable Trade Execution Plans - Newser
Real time social sentiment graph for Longeveron Inc.2025 Trading Recap & Capital Efficiency Focused Ideas - Newser
How to build a custom watchlist for Longeveron Inc.Trade Exit Summary & Verified Chart Pattern Trade Signals - Newser
Using Bollinger Bands to evaluate Longeveron Inc.Entry Point & Free AI Powered Buy and Sell Recommendations - Newser
Backtesting results for Longeveron Inc. trading strategiesEarnings Overview Summary & AI Powered Market Trend Analysis - Newser
Real time scanner hits for Longeveron Inc. explained2025 Price Action Summary & Verified Technical Signals - Newser
Can volume confirm reversal in Longeveron Inc.Market Risk Report & Free High Accuracy Swing Entry Alerts - Newser
Longeveron Secures US Patent License for Stem Cell Technology to Treat Heart Disease. - AInvest
Longeveron (LGVN) Secures Rights to Stem Cell Patent for Cardiac Treatment - Insider Monkey
Longeveron Inc. Faces Regulatory and Manufacturing Challenges Threatening Financial Stability - MSN
Intraday pattern recognizer results for Longeveron Inc.Trade Risk Report & Weekly Sector Rotation Insights - Newser
Longeveron Inc Azioni (LGVN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.96%
1.09%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):